Noticias bursátiles de aptose biosciences
Cotizacion de APTOSE BIOSCIENCES INC.: datos históricos y cotizaciones en tiempo real, gráficos, noticias, análisis, señales de trading, calendario. Aptose Announces Closing of Public Offering of Common Shares. Dec 19 Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting. 5 Nov 2019 05, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company 19 Dec 2019 SAN DIEGO and TORONTO, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, 11 Dec 2019 Promising preclinical data and the acquisition of another small biotech continued to generate enthusiasm among investors. 1 day ago Aptose Biosciences Inc., belongs to Healthcare sector and Biotechnology industry. The company's Market capitalization is $382.73M with the
Aptose Announces Closing of Public Offering of Common Shares. Dec 19 Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting.
Cotizacion de APTOSE BIOSCIENCES INC.: datos históricos y cotizaciones en tiempo real, gráficos, noticias, análisis, señales de trading, calendario. Aptose Announces Closing of Public Offering of Common Shares. Dec 19 Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting. 5 Nov 2019 05, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company 19 Dec 2019 SAN DIEGO and TORONTO, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO,
1 day ago Aptose Biosciences Inc., belongs to Healthcare sector and Biotechnology industry. The company's Market capitalization is $382.73M with the
11 Dec 2019 Promising preclinical data and the acquisition of another small biotech continued to generate enthusiasm among investors.
11 Dec 2019 Promising preclinical data and the acquisition of another small biotech continued to generate enthusiasm among investors.
Información en tiempo real sobre las acciones de Aptose Biosciences (APS) en bolsa, incluyendo precio, gráficos, análisis Noticias - Aptose Biosciences Inc. Cotizacion de APTOSE BIOSCIENCES INC.: datos históricos y cotizaciones en tiempo real, gráficos, noticias, análisis, señales de trading, calendario. Aptose Announces Closing of Public Offering of Common Shares. Dec 19 Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting. 5 Nov 2019 05, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company 19 Dec 2019 SAN DIEGO and TORONTO, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, 11 Dec 2019 Promising preclinical data and the acquisition of another small biotech continued to generate enthusiasm among investors.
5 Nov 2019 05, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company
Aptose Announces Closing of Public Offering of Common Shares. Dec 19 Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting. 5 Nov 2019 05, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company
Información en tiempo real sobre las acciones de Aptose Biosciences (APS) en bolsa, incluyendo precio, gráficos, análisis Noticias - Aptose Biosciences Inc. Cotizacion de APTOSE BIOSCIENCES INC.: datos históricos y cotizaciones en tiempo real, gráficos, noticias, análisis, señales de trading, calendario. Aptose Announces Closing of Public Offering of Common Shares. Dec 19 Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting. 5 Nov 2019 05, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company 19 Dec 2019 SAN DIEGO and TORONTO, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, 11 Dec 2019 Promising preclinical data and the acquisition of another small biotech continued to generate enthusiasm among investors. 1 day ago Aptose Biosciences Inc., belongs to Healthcare sector and Biotechnology industry. The company's Market capitalization is $382.73M with the